Respiratory Disorders Flashcards
Common Cold
caused by virus
nasal discharge caused by viral induced cell injury
allergic rhinitis
immunological response to environmental allergens
requires prior exposure to allergen
Histamine basic
mediator of inflammatory response released by mast cells and basophils released in response to tissue damage and invasion causes most allergy symptoms plays small role in anaphylaxis most present in skin, lungs and gi
histamine types
H1: vasodilation, increased capillary permeability, bronchoconstriction, itching, pain, mucous secretion, neurotransmitter
H2: increased gastric acid secreation
Not related to asthma
Antihistamines
H1 antagonist: bind to H1 receptors, can bind to others and cause side effects
treats mild allergy, motion sickness, insomnia
Effects: sedation, confusion, dizziness, increased reaction time, anticholinergic (dry mouth, constipation, urinary retention, blurry vission) cardiac dysrhythmias
caution w/ benign prostatic hypertrophy and glaucoma
types of antihistamines
Diphenhydramine (benadryl)
loratadine (claritin) non sedative
desloratadine (clarinex) 2nd gen: work peripherally, not in cns (no sedation)
Beta-2 adrenergic agonists facts
-stimulate sympathetic nervous system
-stimulate beta-2 receptors in lungs
cause bronchodilation, decrease histamine release in lungs
-prevent attacks and relieve ongoing attacks
-drug of choice for acute bronchospasm
beta-2 adrenergic agonist types
albuteral : works on central airways
aslmererol
levalbuterol
albuteral derivative: decreses airway resistance, facilitates ucous drainage, increases vital capacity
Ipratropium bromide w/albuterol (combivent)
antichilinergic with beta 2 agonist
ipratropium (atrovent) dilates bronchioles so albuteral can be deposited
combination more effective and has longer duration
leukotriene receptor antagonist
Zafirlukast(accolate)
montelukast sodium (singulair)
zileuton (zyflo)
reduce inflammatory response
glucocorticoids
Beclomethasone (beclovent) MDI
triamcinolone (azmacort) PO
- suppress inflammation by:
- decrease of mediators
- decrease activity of inflammatory cells
- decrease edema of airway
- decrease hyperactivity
- decrease mucous production, increase number of beta 2 receptors and response to beta 2 agonists
status asthmaticus
treatment: beta-2 agonist via nebulizer
epinepgrine, terbutaline, magneium sulfate, leukotriene
IV gluvovorticoid ( prednisone, solumedrol)
Theophylline
- methylxanthine: cns stimulant
- bronchodilator
- maintenance treatment of COPD
- narrow therapeutic range and many drug interactions
- new safer drugs available
adverse effects: diuresis, N/V, anorexia, insomnia, restlessness, convulsions, dysrhythmias